New survey results show almost one-third of life science organizations polled are set to begin quantum computing evaluation this year.

Arrayjet has secured a further contract with CDI Laboratories, which will further enhance CDI’s work in advancing proteomic research and development.

Paige will use this new capital to further accelerate its mission in transforming pathology workflows in the field of cancer, while working closely with biopharma companies to create custom diagnostic and clinical trial solutions to improve patient care.

InSphero AG has announced that the company is launching an academic access program for its Akura™ Flow organ-on-chip technology.

EKF Diagnostics has announced that it has added a novel viral transport media for the safe sample handling and testing of multiple infectious diseases from a single swab to its product range.

The milestone in the project paves the way for production of novel gene therapy drug candidate designed to treat drug-resistant focal epilepsy.

LI-COR near-infrared Western Blots and In-Cell Western™ Assays aim to provide a high-quality, reliable means to get answers to a variety of assays that are key to the study of viruses like SARS-CoV-2.

Avacta has entered into a collaboration with Integumen to evaluate recently generated Affimer reagents that bind the SARS-COV-2 spike protein for the detection of the coronavirus in wastewater, to provide a real-time alert system to warn of localized COVID-19 outbreaks.

New England Biolabs® has announced the launch of the SARS-CoV-2 Rapid Colorimetric LAMP Assay Kit, a Research Use Only (RUO) product that can be used for the visual detection of SARS-CoV-2 RNA.

Metrohm USA has launched the new Profiler-F series of Total Fluorine Analyzers, a single analyzer system capable of measuring the total organic fluorine profile in liquid samples.